Form 4 for MANE Veradermics, Inc
Accepted 2026-08-18 21:10:02 ET · period of report 2026-08-17 · accession 0001628280-26-057816 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-08-18 21:10 | 2026-08-17 | MANE | Durso Timothy August | Chief Technical Off | M - OptEx | $12.19 | +3,452 | 121.6K | +3% | +$42.1K |
| DMT | 2026-08-18 21:10 | 2026-08-17 | MANE | Durso Timothy August | Chief Technical Off | S - Sale+OE | $107.82 | -43.5K | 78.1K | -36% | -$4.69M |
| DT | 2026-08-18 21:10 | 2026-08-17 | MANE | Durso Timothy August | Chief Technical Off | M - OptEx | $0.00 | -3,452 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-17 | M | A | 3,452 | $12.19 | 121,642 | D | — | — | |
| 2 | Common | Common Stock | 2026-08-17 | S | D | 7,918 | $106.71 | 113,724 | D | — | — | (F1) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $106.25 to $106.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 3 | Common | Common Stock | 2026-08-17 | S | D | 16,306 | $107.52 | 97,418 | D | — | — | (F2) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $107.00 to $107.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 4 | Common | Common Stock | 2026-08-17 | S | D | 16,767 | $108.38 | 80,651 | D | — | — | (F3) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $108.00 to $108.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 5 | Common | Common Stock | 2026-08-17 | S | D | 2,348 | $109.34 | 78,303 | D | — | — | (F4) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $109.00 to $109.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 6 | Common | Common Stock | 2026-08-17 | S | D | 161 | $111.28 | 78,142 | D | — | — | |
| 7 | Derivative | Stock Option (Right to Buy) | 2026-08-17 | M | D | 3,452 | $0.00 | 0 | D | $12.19 · — to 2026-12-12 | 3,452 Common Stock | (F5) This option is fully vested and exercisable as of the date hereof. |